While CTCF is a known chromatin insulator, which blocks enhancer function between TADs, it is unclear how CTCF reprograms the epigenetic landscape of prostate cancer cells to drive prostate cancer tumor progression, castration-resistance, and enzalutamide-resistance. This evidence concerns the gene CTCF and prostate cancer.